Article in Kidney360, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
Howard TrachtmanDivision of Pediatric Nephrology, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0006-7778-292
Zubin J ModiDivision of Pediatric Nephrology, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-4410-2853
Wenjun JuDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-9136-8454
Edmond LeeDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0009-2443-6638
Silpa ChinnakotlaDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0005-3360-1886
Susan MassengillAtrium Health Levine Children's Hospital, Charlotte, North Carolina.ORCID 0000-0002-3048-6983
John SedorDepartment of Kidney Medicine, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0002-6780-9168
Laura MarianiDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-6055-764
Yan ZhaiDivision of Pediatric Nephrology, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan.
Wei HaoDepartment of Biostatistics, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-5367-1479
Hailey DesmondDivision of Pediatric Nephrology, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-5866-6644
Sean EddyDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-8578-3443
Karthik RamaniDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-5374-3236
Cathie SpinoDepartment of Biostatistics, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-6157-6738
Matthias KretzlerDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-4064-0582
Funding
Training Program in Clinical & Translationa Research in Human Glomerular DiseaseU54DK083912 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KRETZLER, MATTHIAS · 2009 to 2023
$20.3M
University of Michigan O'Brien Kidney Translational Resource Center (MKTC)U54DK137314 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Subramaniam Pennathur · 2023 to 2026
$4.7M
George M. O'Brien Michigan Kidney Translational Core Center NIH/NIDDK U54DK137314Nephrotic Syndrome Study Network U54-DK-083912NIDDK NIH HHS U54 DK083912NIDDK NIH HHS U54 DK137314
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Precision Medicine Proof-of-Concept Study of a TNF Inhibitor in FSGS and Treatment-Resistant Minimal Change Disease. · full record | Socratic